Literature DB >> 8418761

Juvenile rhabdomyoma. An intermediate form of skeletal muscle tumor in children.

P L Crotty1, R E Nakhleh, L P Dehner.   

Abstract

Two tumors of the buccal soft tissues in children with rhabdomyomatous features are described and further characterized by immunohistochemical studies in both cases and by electron microscopy in one case. Discrete microscopic nodules of elongated, uniform spindle cells with readily identifiable cytoplasmic cross striations replaced existing normal skeletal muscle. In contrast to fetal rhabdomyoma and embryonal rhabdomyosarcoma, there were no immature mesenchymal cells, nor were there individual rhabdomyomatous cells with short, tapered cytoplasmic processes and overtly malignant cytologic features, including mitotic activity. Following excision, one child remains well 46 months later and the other is doing well 7 months after surgery. Some confusion has been created in the literature by the introduction of the terms cellular rhabdomyoma and myxoid fetal rhabdomyoma. We propose that the so-called cellular fetal rhabdomyoma is distinct from the classic fetal rhabdomyoma and may represent the more differentiated juvenile rhabdomyoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418761

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

Review 1.  Perianal fetal rhabdomyoma: case report.

Authors:  P C Lapner; S Chou; C Jimenez
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

2.  Oral polyp as the presenting feature of Beckwith-Wiedemann syndrome in a child.

Authors:  Omar Kujan; Syed Ahmed Raheel; David King; Fareed Iqbal
Journal:  BMJ Case Rep       Date:  2015-08-30

3.  Rhabdomyoma of the parapharyngeal space presenting with dysphagia.

Authors:  Barbara Pichi; Valentina Manciocco; Paolo Marchesi; Raul Pellini; Paolo Ruscito; Antonello Vidiri; Renato Covello; Giusepe Spriano
Journal:  Dysphagia       Date:  2007-10-27       Impact factor: 3.438

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.